Cardlytics (CDLX) Tops Q3 EPS by 26c, Misses on Revenue

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.07), $0.26 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $52 million versus the consensus estimate of $67.33 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
• Deere conference call: 2027 orders up mid-single digits from last year)
• Exchange Bank declares Q3 dividend, CEO to retire in 2027